Mendes, Diana
Machira Krishnan, Sheeja
O’Brien, Esmé
Padgett, Thomas
Harrison, Cale
Strain, W. David
Manca, Andrea
Ustianowski, Andrew
Butfield, Rebecca
Hamson, Elizabeth
Reynard, Charlie
Yang, Jingyan
Funding for this research was provided by:
Pfizer UK
Article History
Received: 26 January 2024
Accepted: 21 March 2024
First Online: 25 April 2024
Declarations
:
: Diana Mendes, Jingyan Yang, Cale Harrison, Rebecca Butfield, Elizabeth Hamson, and Charlie Reynard are employees of Pfizer and may own stocks. Sheeja Machira Krishnan, Thomas Padgett, and Esmé O’Brien are employees of Health Economics and Outcomes Research Ltd, which received funding from Pfizer in relation to the study and in connection with the development of this manuscript. Cale Harrison was an employee of Health Economics and Outcomes Research Ltd at the time of study, received fees for consultancy, and is now an employee of Pfizer. Andrea Manca, Andrew Ustianowski, and W David Strain were paid consultants to Pfizer in relation to the study and in connection with the development of this manuscript. Andrew Ustianowski also received advisory board and/or speaker fees from Gilead Sciences, Merck/MSD, Valneva, GSK/ViiV, Sanofi, unrelated to this study.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.